top of page

Fibrocor Therapeutics

Human-derived, disease-relevant targets for Kidney disease

About

Fibrocor Therapeutics is a biotech startup specializing in early-stage treatments for fibrotic diseases, bringing potentiallu life-changing therapies to patients with few existing options.

INDUSTRY

Life Sciences

William Newsome

Marianna Saporita

​

President and CEO

Senior Director

​

Fibrocor Therapeutics

​

Publications

BIC Presents: Prospecting for Biotech - Podcast

BIC Stage 2 Accelerator - Meet Fibrocor - Video

​

bottom of page